CuoripsCuorips Inc.4894東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

Cuorips FY ending Mar 2022 results

Cuorips brought in ¥13.9M in revenue.

It lost about ¥2683 for every ¥100 of sales at the operating level.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Cuorips sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥24
SG&A
¥2759
Operating loss
¥2683
Net loss
¥2698

Margin funnel (derived from reported values)Gross margin 76.6% → Operating margin -2682.8% → Net margin -2697.7%

Sources

Show source documents (1)
  • EDINET (FSA Japan)

    有価証券報告書-第7期(2022/04/01-2023/03/31)

    ID S100RAR32023-06-30Open

Extracted from XBRL: 32 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.